We systematically de-risk clinical pathways.complex formulations.molecular assets.technology transfers.

End-to-End Molecular Translation

Combining embedded clinical foresight with the SynapTx ™ AI ecosystem to transform complex molecules into viable, market-ready therapies.

Small Molecule API

Characterising & optimising complex active pharmaceutical ingredients to establish a flawless foundation for stability & downstream scalability.

Complex & Novel Formulations

Solving severe solubility & bioavailability limitations to transform challenging molecular assets into robust clinical therapies.

Nanotechnology & Targeted Delivery

Engineering precision modified-release & nano-architectures to strictly control pharmacokinetic exposure & maximise clinical efficacy.

Predictive Biopharmaceutics

Utilising high-dimensional data modelling and pharmacokinetic mapping to anticipate in vivo performance & definitively de-risk trial outcomes.

The SynapTx™ AI Ecosystem

Accelerating complex drug development programs through our secure, on-premise Large Language Model, interpreting critical datasets with absolute intellectual property sovereignty.

Technology Transfer & Scale-Up

Guaranteeing a seamless transition from bench to commercial manufacturing with rigorous, ICH-compliant oversight & clinical precision.

PROPRIETARY AI

The computational engine for clinical success

SynapTx™ is our custom-built, locally-hosted Large Language Model. By keeping all data processing strictly on-premise, we provide tier-one pharmaceutical partners with unprecedented predictive power—without ever exposing proprietary molecular assets to public networks.

Absolute IP Sovereignty

Unlike public AI platforms, SynapTx™ operates entirely within a closed, secure architecture. Your molecular structures, trial data, & formulation IP never leave our local servers, ensuring impenetrable confidentiality.

Predictive Pharmacokinetics

SynapTx™ rapidly digests high-dimensional clinical & physicochemical datasets to model in vivo outcomes. This allows our clinical team to anticipate bioavailability hurdles & engineer precise solutions before manufacturing begins.

Accelerated Technology Transfer

By computationally mapping out the entire formulation lifecycle—from bench-scale variables to commercial manufacturing parameters—SynapTx™ radically compresses the timeline required for successful, ICH-compliant scale-up.

Explore the SynapTx™ Architecture

strategic co-architecture

The technical intellect before the manufacturing floor

Traditional CDMOs rely on trial-and-error chemistry, disconnecting the molecule from biological reality and risking late-stage clinical failure. Dhee Lifesciences operates strictly upstream. We deploy the SynapTx™ AI ecosystem to mathematically solve your formulation architecture before manufacturing begins. We do not sell factory time; we deliver a de-risked, clinic-ready blueprint.

Predictive Formulation Architecture

We abandon the standard 'mix and measure' approach. By feeding your API's physicochemical parameters into the SynapTx™ AI ecosystem, we mathematically model and predict solubility, stability, and bioavailability bottlenecks in silico. This ensures we design a definitively viable formulation architecture before a single physical prototype is ever compounded.

Biostatistically Driven CMC Strategy

Regulatory compliance is insufficient without clinical efficacy. Our Chemistry, Manufacturing, and Controls (CMC) protocols are deeply rooted in biostatistical modelling and human pathophysiology. We align every formulation decision with predictive pharmacokinetic outcomes, ensuring your asset is technically robust and pre-optimised for strict regulatory scrutiny.

Agnostic Technology Transfer

Because we do not sell manufacturing space, our formulation strategies remain entirely unbiased. Once the molecular blueprint is solved and de-risked, we execute a flawless, heavily documented technology transfer to your chosen CDMO. We oversee the handover, ensuring the factory executes the process exactly as we engineered it, without deviation or value loss.

EXPLORE OUR METHODOLOGY

The Lifecycle Continuum

Providing uncompromising scientific and medical oversight across every critical phase of molecular development.

Pre Clinical

Predictive Formulation & De-Risking

Explore the Science

Clinical Translation

Predictive PK & AI Modelling

Leveraging the SynapTx™ AI ecosystem and advanced biostatistics to map high-dimensional pharmacokinetic data, anticipating human outcomes before trials begin.

Discover SynapTx™